Drug Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
SK, Arvelle Sign $530M Deal for Antiepileptic Drug
Mark Altmeyer named president and chief executive of Arvelle02.15.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
Passage Bio Officially Launches
With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases02.15.19
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | Methods Development | R&D
Axovant Announces Formation of Arvelle Therapeutics
Along with the strategic transition of legacy small molecule team into the newly formed company02.15.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
AbCellera & Novartis Announce Collaboration
AbCellera to apply technology to advance programs on up to ten targets elected by Novartis02.15.19
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
NeoTX, MedImmune Announce Clinical Collaboration
To support Phase 1b/2 studies investigating ANYARA in combination with AstraZeneca's IMFINZI02.11.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Eton & Sintetica Enter Supply Agreement
To obtain U.S. marketing rights to two high-volume, near-term product launch candidates.02.11.19
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
3SBio, Verseau Establish Immuno-Oncology Devt. Collaboration
3SBio will fund and conduct antibody development and GMP manufacturing02.11.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
MedPharm & Palvella Expand Partnership
For developing a new treatment for the debilitating rare disease, pachyonychia congenita02.11.19
-
Breaking News | Drug Development | Industry News
IFM Therapeutics Launches Subsidiary
IFM Due to advance cGAS/STING antagonists for serious inflammatory and autoimmune diseases02.11.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Merck KGaA, GSK Ink $4.2B Immunotherapy Deal
Eight immuno-oncology clinical development studies ongoing or expected to commence in 2019Videos
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
Pathios, Sygnature Announce Partnership
For an integrated drug discovery program against a novel G Protein-Coupled Receptor (GPCR) target02.07.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Evotec & Galapagos Enter Global Collaboration
Focused on a novel target for fibrosis and other indications02.07.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
EMD Serono Expands Bio R&D Facility
Will invest $70 million to expand Billerica, MA facility with a new 145,000 sq.-ft. building02.06.19
-
Drug Development | Information Technology
Leveraging AI to Advance Discovery, Development and Delivery
Sanofi leveraged the Linguamatics NLP AI text-mining software to identify links between specific genes, diseases, and drug sensitivityOnline Exclusives Kristin Brooks, Contract Pharma 02.05.19
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
MilliporeSigma Funds Small Biotechs
Awards grants to biotechs tackling cancer and cardiovascular disease02.05.19
-
Bio News | Collaborations & Alliances | Drug Development | Industry News
Taiho and Cullinan Enter Cancer Collaboration
Will develop TAS6417, novel EGFR tyrosine kinase inhibitor02.05.19
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Merck KGaA, GSK Ink $4.2B Immunotherapy Deal
Eight immuno-oncology clinical development studies ongoing or expected to commence in 201902.05.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
Polyphor Awarded $5.6M Grant from CARB-X
To support the development of a novel OMPTA candidate to treat the deadliest and most resistant Gram-negative bacterial pathogens02.05.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Methods Development | R&D
Xencor, Genentech Enter Research & Licensing Deal
To develop and commercialize Novel IL-15 Immune Activating Cytokines02.05.19
-
Breaking News | Clinical Trials | CRO News | Drug Development
